Publications

Results from oritavancin resistance surveillance programs (2011-2014): Clarification for using vancomycin as a surrogate to infer oritavancin susceptibility. by Jones RN, Moeck G, Arhin FF, Dudley MN, Rhomberg PR and Mendes RE published in Antimicrob. Agents. Chemother. 2016; 60 (5): 3174-3177

View publication